Mind Space provides safe and revitalizing space for those suffering from depression, anxiety, PTSD, and chronic pain.
Mind Space Ketamine Clinic …
The post Drs. Bracken, Perez, and Lee Open Innovative Spa for the Mind With New Ketamine Infusion Clinic: Mind Space first appeared on Enrose Magazine.
Jacob’s deep expertise will help the company define and lead a new path forward by expanding its footprint in digital patient care.
SEATTLE, May 11, 2023 (Newswire.com)
–
MedBridge, the industry-leading digital health and online education solution for healthcare professionals and organizations across the care continuum, is excited to announce Sarah Jacob has joined the company’s executive team as its first Chief Product Officer.
Jacob has been a leader in the digital health technology space for over 10 years and is an expert at developing differentiated products and building world-class product organizations. With her considerable experience, skill, and talent, Jacob will help guide the future of MedBridge as the company continues to expand its digital patient care solutions designed to advance the healthcare industry through a time of rapid change.
With healthcare organizations under pressure to keep up with evolving patient needs, MedBridge has continued its ongoing commitment to building digital patient care solutions that support a more personalized healthcare experience. As the company’s growth accelerates, it has added new talent to the executive team and revised its web domain from medbridgeed.com to medbridge.com to reflect an expansion from education towards an increasingly more holistic digital care experience.
“The opportunity to join a world-class organization on a mission to change the way care is delivered to patients is incredibly exciting,” said Jacob. “MedBridge is uniquely positioned to engage patients in a way the industry hasn’t seen before, and I’m thrilled to be able to lead that effort. The products we are taking to market to blaze the trail for digital patient care will be industry-defining.”
MedBridge is the solution of choice for nine of the top 10 physical therapy private practices and hospital systems, and six of the top 10 home health agencies. Organizations leveraging the MedBridge Digital Care Ecosystem have already experienced striking results, including 69 percent better patient retention, 243 percent increased patient activation, and 27 percent better FOTO effectiveness scores. In overseeing MedBridge’s product management, design, and operations, Jacob will play a key part in building on and expanding these successes for the future of healthcare.
“With a large enterprise market presence that includes over half of the physical therapy market and partnerships with many leading healthcare organizations in the country, MedBridge is in a unique position to bring the value of therapy to more patients,” said Leigh Wager, Vice President, Strategic Solution at MedBridge. “We’re so pleased about the experience, passion, and product vision Sarah brings to the MedBridge team, our clients, and their patients. It’s an incredibly exciting time to be in healthcare.”
Contact Information:
Amelia Ramstead
Marketing Communications Manager
Original Source:
Sarah Jacob Joins MedBridge Executive Team as Its First Chief Product Officer
The post Sarah Jacob Joins MedBridge Executive Team as Its First Chief Product Officer first appeared on Enrose Magazine.
UCHealth Medical Center of the Rockies and Franciscan Health Crown Point Winners of Inaugural Peregrine Trauma Innovation Award
…
The post Winners of the 2023 Peregrine Award for Trauma Innovation Announced first appeared on Enrose Magazine.
EAST PALESTINE, Ohio, May 11, 2023 (Newswire.com)
–
Dr. Beatrice Golomb, professor of medicine at University of California San Diego School of Medicine (https…
The post Study Initiated to Track Health and Laboratory/Blood Markers in Residents of East Palestine and Beyond in Areas Apparently Affected by the Plume first appeared on Enrose Magazine.
NEW YORK, May 11, 2023 (Newswire.com)
–
As Mother’s Day approaches, Bitvae, committed to making oral care easy and enjoyable, is excited to celebrate the occasion by offering a collection of high-quality, easy-to-use products perfect for every mom.
Oral health is an essential aspect of overall health and wellness, and Bitvae is committed to providing the tools and knowledge necessary for moms to keep their family’s oral health in top shape. “We understand that oral care is an integral part of every family’s daily routine, and we want to make it as easy and enjoyable as possible for moms,” said Hugh Zou, the founder and CEO of Bitvae.
Bitvae’s D2 Electric Toothbrush and S2 Smart Electric Toothbrush are the perfect addition to any busy mom’s oral care routine. These toothbrushes have received the American Dental Association (ADA) Seal of Acceptance, so you can rest assured that mom will be getting a high-quality product. With over 2,000 5-star reviews on Amazon, these electric toothbrushes are trusted by many satisfied customers.
For moms looking to add a pop of color to their bathroom, Bitvae offers the D2 Electric Toothbrush and R2 Rotating Electric Toothbrush in a stunning and trendy shade of pink. Moreover, for moms who want to take their oral care routine to the next level, Bitvae offers the C2 Portable Water Flosser, available in the same chic pink shade. This powerful flosser removes up to 99.9% of food debris and dental plaque, ensuring a thorough clean that brushing alone cannot provide. With its compact design, the C2 is perfect for busy moms on the go who want to maintain healthy teeth and gums wherever they are.
“Bitvae’s mission is to make oral care a daily routine that is simple, enjoyable, and effective for everyone. As Mother’s Day approaches, we want to empower moms to take control of their family’s oral health with confidence,” said Hugh, founder and CEO of Bitvae. “That’s why we’ve infused the latest technology into our kid’s smart electric toothbrush, making it fun and easy for moms to teach their children the importance of maintaining a good oral care routine from an early age.”
Furthermore, Bitvae recently launched Teeth Whitening Strips for sensitive teeth, made with natural minerals and revolutionary ingredients like Dead Sea salt. These whitening strips not only whiten like a professional-grade treatment but also strengthen tooth enamel and reduce sensitivity.
This Mother’s Day, give the gift of a healthy smile with Bitvae’s affordable and high-quality oral care products.
About Bitvae
Established in Texas, Bitvae is committed to making oral care easy and enjoyable. Bitvae infuses the latest technologies into thoughtful products that fit into their customers’ lifestyles and are perfect for use at home and on the go.
For more information, check out Bitvae’s storefront on Amazon or website and stay up to date with the brand on Instagram and Facebook (@bitvae.official).
Contact Information:
Lens Watson
PR Manager
Original Source:
Celebrate Mother’s Day With Bitvae’s Revolutionary Oral Care Products
The post Celebrate Mother’s Day With Bitvae’s Revolutionary Oral Care Products first appeared on Enrose Magazine.
Democratizing Access to HEDIS Digital Content Advances Digital Quality Measurement
WASHINGTON, May 11, 2023 (Newswire.com)
–
The National Committee for Quality Assurance (NCQA) today announced it is publishing requirements and open-source software for interpreting and executing clinical quality language (CQL) so any organization or software developer can use HEDIS Digital Content Services.
This action advances digital health care quality measurement by making it easy for developers to understand requirements and test capabilities to work with digital measure content from NCQA. The move is part of NCQA’s larger goal of building better health care, better choices and better health by convening and aligning stakeholders around digital quality requirements and testing.
“There is a great need for data sharing and interoperability between payers and providers to ensure timely and accurate measurement of health care quality,” said NCQA Chief Technology Officer Edward Yurcisin. “We’re advancing the standard so anyone anywhere can use digital quality content from NCQA or other sources.”
Clinical Quality Language is an expression language curated by HL7 that CMS, NCQA and others have adopted for digital quality measures. NCQA uses CQL to provide digital HEDIS measure content, including the NCQA Digital Content Services product line launched in early 2023. Incorporating FHIR CQL engine code in open-source code will help organizations use standards-based electronic health data with quality measures and clinical decision support to improve transparency and patient care.
“Sharing FHIR CQL know-how helps diverse organizations and technology stacks support CQL and HEDIS digital content,” continued Yurcisin. “That, in turn, helps embed quality in health systems everywhere and will help make FHIR CQL engine code for quality measures faster, more scalable and more extensible.”
Firely manages the open-source .NET repository where NCQA will publish CQL software. NCQA and Firely will convene interested parties around requirements and testing.
To learn more about FHIR CQL in support of digital quality measurement, contact the NCQA Digital Quality Community Director.
About NCQA
NCQA is a private, nonprofit organization dedicated to improving health care quality. NCQA Accredits and Certifies a wide range of health care organizations. It also recognizes clinicians and practices in key areas of performance. NCQA’s Healthcare Effectiveness Data and Information Set (HEDIS®) is the most widely used performance measurement tool in health care. The organization received the prestigious James W. Rouse Excellence in Diversity Award for demonstrating a commitment to promoting a diverse, healthy workplace. NCQA’s website (ncqa.org) contains information to help consumers, employers and others make informed health care choices. NCQA can also be found on Twitter @NCQA and on LinkedIn at linkedin.com/company/NCQA.
Contact Information:
Theresa Masnik
SHIFT Communications
Original Source:
NCQA Makes ‘Engine’ Software Requirements Open Source, Expanding Access to HEDIS Digital Content
The post NCQA Makes ‘Engine’ Software Requirements Open Source, Expanding Access to HEDIS Digital Content first appeared on Enrose Magazine.
NEW YORK, May 11, 2023 (Newswire.com)
–
Syndesis Health announced today that it has signed a research collaboration and information sharing agreement with Fun…
The post Syndesis Health & LaCardio Sign Research Collaboration Agreement first appeared on Enrose Magazine.
Optimizing Proactive, Preventative, and Data-Driven Care for Corporate Athletes
ATLANTA, May 11, 2023 (Newswire.com)
…
The post Athletic Training Solutions Selects AMP to Further Automate Nationally Recognized Health & Safety Service Offerings first appeared on Enrose Magazine.
FarmaKeio Outsourcing is proud to announce the release of its latest innovation, the only patented hormone pellet with triamcinolone developed in an FDA-registered 503B outsourcing facility. The pellet is set to provide a new and revolutionary solution to hormone replacement therapy for men and women.
SOUTHLAKE, Texas, May 10, 2023 (Newswire.com)
–
FarmaKeio Outsourcing (FKO), a leading pharmaceutical outsourcing facility in the United States, has been granted a patent to produce testosterone and triamcinolone subcutaneous hormone pellets. The patent includes 23 claims, issued by the United States Patent and Trademark Office (USPTO), recognizing the company’s innovative approach to compounding hormone therapy and solidifying its position as a leader in the field of pharmaceutical development.
Unlike other hormone therapies, which may require frequent injections or daily pills, FarmaKeio Outsourcing’s hormone pellets provide a sustained release of testosterone and triamcinolone, allowing patients to enjoy the benefits of these hormones for extended periods of time. These pellets are inserted subcutaneously and gradually release the hormone over several months, reducing the need for frequent dosing and allowing patients to focus on their daily lives.
“We are thrilled to receive this patent for our subcutaneous hormone pellets,” said FarmaKeio Outsourcing’s CEO, Dan DeNeui. “Our team has worked tirelessly to develop this innovative approach to hormone therapy, and we are excited to be able to offer this option to patients in need.”
In addition to providing a more convenient method of hormone therapy, FarmaKeio’s pellets offer a unique formulation that is not available from any other FDA 503B registered outsourcing facility in the US. This proprietary formulation has been carefully designed and tested and it represents a significant breakthrough in the field of hormone therapy.
“We believe that our hormone pellets have the potential to revolutionize the way that hormone therapy is delivered,” said DeNeui. “By offering a sustained release of testosterone and triamcinolone, we can provide patients with a more consistent and reliable treatment option that can improve their quality of life.”
The issuance of this patent is a significant milestone for FarmaKeio Outsourcing, and it reflects the company’s ongoing commitment to innovation and excellence in pharmaceutical development. As the demand for hormone therapy continues to grow, FarmaKeio is well-positioned to meet the needs of patients and healthcare providers alike with its cutting-edge hormone pellets.
“We are confident that our hormone pellets will become the gold standard for hormone therapy, and we look forward to working with healthcare providers and patients to make this technology available to as many people as possible,” said Chief Operating Officer Cody Boatman.
The hormone pellet with triamcinolone is a groundbreaking new product that is set to revolutionize the hormone replacement therapy industry. With its unique combination of hormones and anti-inflammatory properties, it provides patients with a more comfortable treatment option. The pellet is an exclusive feature of The EvexiPEL Method, created and founded by Terri DeNeui, DNP, APRN, ACNP-BC, and is available exclusively through FarmaKeio Outsourcing, an FDA-registered 503B facility. With this new product, FarmaKeio Outsourcing is once again proving its commitment to providing innovative solutions to hormone replacement therapy.
About FarmaKeio Outsourcing
FarmaKeio Outsourcing is a leading FDA-registered 503B pharmaceutical outsourcing facility that specializes in providing specific custom compounded medications to healthcare providers and facilities across the United States. FarmaKeio Outsourcing is committed to providing innovative, patient-centered solutions that meet the unique needs of their clients.
FarmaKeio Outsourcing offers an unwavering commitment to quality, safety, and compliance, operating a state-of-the-art facility that is cGMP compliant and undergoes rigorous testing and quality assurance procedures to ensure the highest level of quality and safety.
FarmaKeio Outsourcing provides exceptional customer service and support, ensuring that their clients have access to the resources and expertise necessary to make informed decisions about patient care. FarmaKeio Outsourcing is a trusted partner for healthcare providers looking to offer the most innovative and advanced care solutions to their patients.
Contact Information:
Danielle Tworek
Director of Marketing
5613253904
Original Source:
FarmaKeio Outsourcing Announces Patented Formulation of Revolutionary Hormone Therapy Pellet
The post FarmaKeio Outsourcing Announces Patented Formulation of Revolutionary Hormone Therapy Pellet first appeared on Enrose Magazine.
collaboratehealth® partners with MedBridge Healthcare to provide sleep apnea screening, diagnosis and therapy monitoring through their current technology platform.
…
The post collaboratehealth Announces Partnership With MedBridge Healthcare to Add Sleep Diagnostics to Their Hospital to Home 30-Day Readmission Reduction Program first appeared on Enrose Magazine.
